SOT Welcomes New Affiliate: Regeneron Pharmaceuticals, Inc.

We are pleased to announce that Regeneron Pharmaceuticals, Inc. has become the newest SOT Affiliate. Regeneron is a biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions.This company has active research and development programs in many disease areas, including ophthalmology, inflammation, cancer, and hypercholesterolemia. Founded in 1988, the company is headquartered in Tarrytown, New York. Demonstrate your organization’s support of the Society of Toxicology by becoming an SOT Affiliate. For additional information, visit the Affiliates section of the SOT website or contact Marcia Lawson at SOT Headquarters.


Recent Stories
SOT Concludes a Successful 2020 Virtual Meeting

Engage with the 2020 Virtual ToxExpo

Reflections on the 2020 Virtual Undergraduate Education Program